The UCL spinout has secured an additional licence to a protein that aims to reduce side effects associated with its Car T immuno-oncological approach.

Iluminos will commercialise compounds with the potential to combat neurodegenerative diseases such as Alzheimer's.

GraphicsFuzz will launch a security testing tool for graphics drivers to catch potential flaws using a metamorphic approach.

Harvard University has spun out NuProbe to commercialise a molecular blood test based on research by Peng Yin and David Zhang at the Wyss Institute.

Omniscient has developed a dual-view endoscope for conducting colonoscopies that could detect pre-cancerous growths currently missed by front-facing devices.

Orchard Therapeutics has licensed a range of gene therapies from GSK, which will get a 19.9% stake in the UCL spinout as part of the deal.

The number of Illinois university-linked businesses founded in the past five years has more than doubled on the preceding period.

Satt IDF Innov has licenced research at Institut Cochin and Institut Pierre-Louis to SkinDemic, which will now commercialise a treatment for acne and Kaposi's sarcoma.